Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12415
Title: Myostatin inhibition: a new treatment for androgen deprivation-induced sarcopenia?
Austin Authors: Grossmann, Mathis 
Affiliation: Department of Medicine Austin Health, University of Melbourne, and Endocrine Unit, Austin Health, Heidelberg, Victoria 3052, Australia
Issue Date: 1-Oct-2014
Publication information: The Journal of Clinical Endocrinology and Metabolism; 99(10): 3625-8
Gov't Doc #: 25279574
URI: http://ahro.austin.org.au/austinjspui/handle/1/12415
DOI: 10.1210/jc.2014-3290
URL: https://pubmed.ncbi.nlm.nih.gov/25279574
Type: Journal Article
Subjects: Androgen Antagonists.adverse effects
Body Mass Index
Humans
Immunoglobulin Fc Fragments.adverse effects
Male
Muscle, Skeletal.drug effects
Myostatin.antagonists & inhibitors
Prostatic Neoplasms.drug therapy
Recombinant Fusion Proteins.adverse effects
Appears in Collections:Journal articles

Show full item record

Page view(s)

4
checked on Dec 7, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.